PAVmed Inc. (NASDAQ:PAVM) Q2 2023 Earnings Conference Call August 16, 2023 8:30 AM ET

Company Participants

Michael Parks - Vice President of Investor Relations

Lishan Aklog - Chairman and Chief Executive Officer

Dennis McGrath - Executive Vice President and Chief Financial Officer

Conference Call Participants

Frank Takkinen - Lake Street Capital Markets

Ed Woo - Ascendiant Capital

Ross Osborn - Cantor Fitzgerald

Anthony Vendetti - Maxim Group

Operator

Good day, and welcome to the PAVmed Second Quarter 2023 Business Update Conference Call. [Operator Instructions] Please note, today's event is being recorded.

I would now like to turn the conference over to Michael Parks, Vice President of Investor Relations. Please go ahead, sir.

Michael Parks

Thank you, Rocco. Good morning, everyone, and thank you for participating in today's second quarter 2023 business update call.

The press release announcing our business update for the company and financial results for the three and six months ended June 30, 2023 is available on the PAVmed website. Please take a moment to read the disclaimer about forward-looking statements.

The business update press release and this conference call include forward-looking statements, and these forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from statements made. Factors that could cause actual results to differ are described in the disclaimer and in our filings with the U.S. Securities and Exchange Commission.

For a list and description of these and other important risk factors or risks and uncertainties that may affect future operations, see Part I Item 1A entitled Risk Factors and PAVmed's most recent annual report on Form 10-Q filed with the SEC and subsequent updates filed in quarterly reports on Form 10-Q and any subsequent Form 8-K filings.

As required by law, PAVmed disclaims any intentions or obligations to publicly update or revise any forward-looking statements to reflect changes in expectations or in events, conditions or circumstances on which the expectations may be based or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.

I would now like to turn the call over to Dr. Lishan Aklog, PAVmed Chairman and CEO. Dr. Aklog?

Lishan Aklog

Thank you, Mike, and good morning, everyone. Great to have you here. Thank you for taking the time to join us.

We spent some time catching you up on the business side of things for Veris and Lucid. As you know, we did do a call -- Lucid call yesterday and that call is on our website. So, I'll limit my -- the topics of Lucid and focus more on Veris.